Alberto Grandi obtained his Bachelor Degree in Biological Sciences (specialization in Ecology) in 2005 and two years later his Master Degree in Biodiversity, Ecology and Evolution. From 2008 to 2015 he joined the Biotech Company Externautics SpA where he was instrumental in the discovery and characterization of novel protein biomarkers in human cancers. While working at Externautics he obtained his PhD in Cellular Biology and Biochemistry. In 2015 Dr. A. Grandi joined the Toscana Life Sciences Foundation to become a senior scientist and a key contributor to the development of a novel vaccine platform for infectious diseases and cancer. He is currently responsible for implementing strategies to engineer bacterial Outer Membrane Vesicles with cancer antigens and to set-up and validate in vitro and in vivo cancer models.